IL13 and airway hyperresponsiveness: From a physiological mechanism perspective, estrogen exerts a direct protective effect on asthma by inhibiting Th2-type inflammatory responses (e.g., reducing the release of IL-4, IL-5, and IL-13) and lowering airway hyperresponsiveness (48).